Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test CYP2C19 (Clopidogrel) Genotyping Test is 5 business days.

What are the prerequisites for the test CYP2C19 (Clopidogrel) Genotyping Test

  • Patients must be prescribed clopidogrel (Plavix) by their healthcare provider
  • Patients must not have any contraindications to clopidogrel therapy
  • Patients must not have a history of bleeding disorders
  • Patients must not be pregnant or breastfeeding
  • Patient's healthcare provider must order the CYP2C19 genotyping test

What are the measure values for the test CYP2C19 (Clopidogrel) Genotyping Test

  • Test Name: CYP2C19 (Clopidogrel) Genotyping Test
  • Measure Values:
    • Normal/Normal (EM): Indicates normal metabolizer status
    • Normal/Intermediate (IM): Indicates intermediate metabolizer status
    • Normal/Poor (PM): Indicates poor metabolizer status
    • Intermediate/Intermediate (IM): Indicates intermediate metabolizer status
    • Intermediate/Poor (PM): Indicates poor metabolizer status
    • Poor/Poor (PM): Indicates poor metabolizer status

What does this test CYP2C19 (Clopidogrel) Genotyping Test identify?

  • The CYP2C19 (Clopidogrel) Genotyping Test identifies genetic variations in the CYP2C19 gene that may affect an individual's response to the medication Clopidogrel.
  • Specifically, the test looks for variations in the CYP2C19 gene that can result in poor metabolizers of Clopidogrel, leading to reduced effectiveness of the medication in preventing blood clots.
  • This information can help healthcare providers determine the most appropriate dose of Clopidogrel for a patient based on their genetic profile, potentially improving the efficacy and safety of treatment.

Why is this test CYP2C19 (Clopidogrel) Genotyping Test taken?

  • Reason for Test: The CYP2C19 (Clopidogrel) Genotyping Test is taken to determine an individual's genetic variation in the CYP2C19 enzyme. This enzyme plays a crucial role in metabolizing clopidogrel, a commonly prescribed antiplatelet medication used to prevent blood clots. Genetic variations in the CYP2C19 gene can affect how effectively the body processes clopidogrel, leading to potential differences in treatment outcomes and risk of adverse events.

No FAQs available.

Customer Google Rating